Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for sickle cell disease ... s 3.2% decline. Image Source: Zacks ...

With the exception of "Editorial use only" photos (which can only be used in editorial projects and can't be modified), the possibilities are limitless. Learn more about royalty-free images or view ...

With the exception of "Editorial use only" photos (which can only be used in editorial projects and can't be modified), the possibilities are limitless. Learn more about royalty-free images or view ...

India faces a critical shortage of 41 million blood units annually. Doctors stress that the country needs lifelong donors for ...

Abstract: Sickle cell anaemia is a critical inherited blood abnormality ... This study explores the utilization of advanced DL approaches to enhance the detection of SCA in microscopic images, aiming ...

Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

Sickle cell disease is a chronic blood disorder that requires careful management, not only through medications and medical ...

These are complex therapies that require support and informed decision-making. Shine the Light on Sickle Cell is about bringing visibility not only to the promise of a better future, but also to ...

Symptoms brought on by sickle cell anemia have changed for Jayden over time, said Wilsey. In the last three years, Jayden has experience debilitating chronic pain from the disease, which impacts ...

Sickle Cell Disease is the most common inherited blood disorder in the United States, affecting the lives of 100,000 people, ...